Davis Todd C bought LGND
March 4, 2025 · Form 4 insider transaction
Davis Todd C bought 21,382 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,382
Price
$0.00
Total value
N/A
InsiderDavis Todd C
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 4, 2025
Filing dateMarch 6, 2025
Shares owned after151,724
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2026; February 15, 2027; and February 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.